卵圆孔未闭封堵术的研究进展

Abstract
Figure/Table
References (25)
Related Citation (2)

Download: PDF (535 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Patent foramen ovale is one of the most common congenital heart diseases, which is closely related to cryptogenic stroke, migraine, decompression illness, platypnea-orthodeoxia syndrome and other diseases. Preventive closure for high-risk population and therapeutic closure for inpatients have been widely carried out in clinic practice. With the change of treatment concept and the improvement of medical level, the closure of patent foramen ovale has developed a variety of variants involving different surgical approaches and guidance methods. This article reviews the application of patent foramen ovale occlusion, in order to provide new ideas for clinical evaluation of the best surgical method for patients with patent foramen ovale.

Key words： Patent foramen ovale Percutaneous intervention Echocardiography guidance X-ray guidance Occluder

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Jianxiong1 WANG Feng2 CHEN Kaiyuan1 HU Xuanyi1

Cite this article:

LI Jianxiong1 WANG Feng2 CHEN Kaiyuan1 HU Xuanyi1. Research progress on closure of patent foramen ovale[J]. 中国医药导报, 2021, 18(7): 43-46.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2021/V18/I7/43

[1] 中华医学会心血管内科分会，中国医师协会心血管内科分会.卵圆孔未闭预防性封堵术中国专家共识[J].中国循环杂志，2017，32（3）：209-214.
[2] Mas JL，Derumeaux G，Guillon B，et al. Patent foramen ovale closure or anticoagulation vs.antiplatelets after stroke [J]. N Engl J Med，2017，377（11）：1011-1021.
[3] S?覬ndergaard L，Kasner SE，Rhodes JF，et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke [J]. N Engl J Med，2017，377（11）：1033-1042.
[4] Saver JL，Carroll JD，Thaler DE，et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke [J]. N Engl J Med，2017，377（11）：1022-1032.
[5] Lee PH，Song JK，Kim JS，et al. Cryptogenic stroke and high-risk patent foramen ovale：the DEFENSE-PFO trial [J]. J Am Coll Cardiol，2018，71（20）：2335-2342.
[6] Mattle HP，Evers S，Hildick-Smith D，et al. Percutaneous closure of patent foramen ovale in migraine with aura，a randomized controlled trial [J]. Eur Heart J，2016，37（26）：2029-2036.
[7] Rayhill M，Burch R. PFO and migraine：is there a role for closure？ [J]. Curr Neurol Neurosci Rep，2017，17（3）：20.
[8] Villablanca PA，Briston DA，Rodés-Cabau J，et al. Treatment options for the closure of secundum atrial septal defects：a systematic review and meta-analysis [J]. Int J Cardiol，2017，241：149-155.
[9] Moon J，Kang WC，Kim S，et al. Comparison of outcomes after device closure with transseptal puncture and standard technique in patients with patent foramen ovale and ischemic events [J]. J Interv Cardiol，2016，29（4）：400-405.
[10] Zhu P，Qiang H，Liu F，et al. Clinical evaluation of percutaneous and intra-operative device closure of atrial septal defects under transesophageal echocardiographic guidance：one center experience and mid-term follow-up [J]. J Cardiothorac Surg，2020，15（1）：20.
[11] Chen Q，Cao H，Chen ZY，et al. Comparative study of the transcatheter and transthoracic device closure treatments for atrial septal defect：a Chinese single-institution experience [J]. Medicine（Baltimore），2017，96（11）：e6316.
[12] Manolis AS，Koulouris S，Rouska E，et al. Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy：single operator experience in 110 consecutive patients [J]. Indian Heart J，2018，70（1）：24-31.
[13] Faccini A，Butera G. Atrial septal defect （ASD） device trans-catheter closure：limitations [J]. J Thorac Dis，2018， 10（Suppl 24）：S2923-S2930.
[14] Jung SY，Choi JY. Transcatheter closure of atrial septal defect：principles and available devices [J]. J Thorac Dis，2018，10（Suppl 24）：S2909-S2922.
[15] Rat N，Muntean I，Opincariu D，et al. Cardiovascular imaging for guiding interventional therapy in structural heart diseases [J]. Curr Med Imaging Rev，2020，16（2）：111-122.
[16] Han Y，Zhang X，Zhang F. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke：single center experience in 132 consecutive patients [J]. J Cardiothorac Surg，2020，15（1）：11.
[17] 杨滔，欧阳文斌，赵广智，等.单纯经胸超声心动图引导下行经皮卵圆孔未闭封堵术的临床研究[J].中国循环杂志，2019，34（1）：77-80.
[18] 李慧慧，梁栋，余智祥，等.心腔内超声在心脏介入中的应用[J].心脏杂志，2020，32（2）：197-201.
[19] Alkhouli M，Hijazi ZM，Holmes DR，et al. Intracardiac ech-ocardiography in structural heart disease interventions [J]. JACC Cardiovasc Interv，2018，11（21）：2133-2147.
[20] 刘文娟，张玉顺，成革胜，等.两种不同封堵器对不明原因脑卒中合并大量右向左分流患者卵圆孔未闭的疗效对比[J].中国循环杂志，2018，33（4）：385-389.
[21] Scalise F，Auguadro C，Sorropago G，et al. Long-term contrast echocardiography and clinical follow-up after percutaneous closure of patent foramen ovale using two different atrial septal occluder devices [J]. J Interv Cardiol，2016，29（4）：406-413.
[22] Araszkiewicz A，S?覥awek S，Trojnarska O，et al. Interventional closure of patent foramen ovale with Nit-occlud?誖 device in prevention of recurrent neurologic events-long-term results [J]. Catheter Cardiovasc Interv，2018， 92（1）：159-164.
[23] Sun W，Wang B，He L，et al. Feasibility and safety of transnasal transesophageal echocardiography guiding left atrial appendage closure without general anesthesia [J]. JACC Cardiovasc Imaging，2020，13（9）：2043-2044.
[24] Maini B. Real-time three-dimensional intracardiac echo-cardiography：an early single-center experience [J]. J Invasive Cardiol，2015，27（1）：E5-E12.
[25] He L，Cheng GS，Du YJ，et al. Feasibility of device closure for multiple atrial septal defects with an inferior sinus venosus defect：procedural planning using three-dimensional printed models [J]. Heart Lung Circ，2019，29（6）：914-920.